Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3071% below fair value
$3.86−0.31 (-7.43%)
Close on Nov 12, 2026Market cap $72.56MP/E –Yield –
Outset Medical total assets
Total assets on the balance sheet at the end of each period.
Outset Medical's total assets was $230.41M at Sep 30, 2026. For fiscal 2025 it was $264.50M, down 4.1% from the year before. The highest annual figure on record is $463.46M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $264.50M | -4.1% |
| FY2024 | Dec 31, 2024 | $275.80M | -12.1% |
| FY2023 | Dec 31, 2023 | $313.80M | -21.6% |
| FY2022 | Dec 31, 2022 | $400.12M | -13.7% |
| FY2021 | Dec 31, 2021 | $463.46M | +14.8% |
| FY2020 | Dec 31, 2020 | $403.83M | +357.0% |
| FY2019 | Dec 31, 2019 | $88.37M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $230.41M | -16.9% |
| Q2 FY2026 | Jun 30, 2026 | $242.39M | -16.1% |
| Q1 FY2026 | Mar 31, 2026 | $249.45M | -17.2% |
| Q4 FY2025 | Dec 31, 2025 | $264.50M | -4.1% |
| Q3 FY2025 | Sep 30, 2025 | $277.26M | -5.3% |
| Q2 FY2025 | Jun 30, 2025 | $288.80M | -8.2% |
| Q1 FY2025 | Mar 31, 2025 | $301.21M | -13.0% |
| Q4 FY2024 | Dec 31, 2024 | $275.80M | -12.1% |
| Q3 FY2024 | Sep 30, 2024 | $292.89M | -4.8% |
| Q2 FY2024 | Jun 30, 2024 | $314.53M | -6.0% |
| Q1 FY2024 | Mar 31, 2024 | $346.24M | -4.5% |
| Q4 FY2023 | Dec 31, 2023 | $313.80M | -21.6% |
| Q3 FY2023 | Sep 30, 2023 | $307.55M | -15.9% |
| Q2 FY2023 | Jun 30, 2023 | $334.44M | -16.6% |
| Q1 FY2023 | Mar 31, 2023 | $362.67M | -16.0% |
| Q4 FY2022 | Dec 31, 2022 | $400.12M | -13.7% |
| Q3 FY2022 | Sep 30, 2022 | $365.72M | -25.2% |
| Q2 FY2022 | Jun 30, 2022 | $401.24M | -20.5% |
| Q1 FY2022 | Mar 31, 2022 | $431.74M | +13.7% |
| Q4 FY2021 | Dec 31, 2021 | $463.46M | +14.8% |
| Q3 FY2021 | Sep 30, 2021 | $488.80M | +14.7% |
| Q2 FY2021 | Jun 30, 2021 | $504.81M | +471.3% |
| Q1 FY2021 | Mar 31, 2021 | $379.83M | – |
| Q4 FY2020 | Dec 31, 2020 | $403.83M | – |
| Q3 FY2020 | Sep 30, 2020 | $426.02M | – |
| Q4 FY2019 | Dec 31, 2019 | $88.37M | – |
See a number that looks wrong?